ATE235901T1 - Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen - Google Patents

Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen

Info

Publication number
ATE235901T1
ATE235901T1 AT96927931T AT96927931T ATE235901T1 AT E235901 T1 ATE235901 T1 AT E235901T1 AT 96927931 T AT96927931 T AT 96927931T AT 96927931 T AT96927931 T AT 96927931T AT E235901 T1 ATE235901 T1 AT E235901T1
Authority
AT
Austria
Prior art keywords
pct
trimethylhydrazinium
gamma
treatment
pharmaceutical composition
Prior art date
Application number
AT96927931T
Other languages
English (en)
Inventor
Ivars Kalvinsh
Maris Veveris
Original Assignee
Ivars Kalvinsh
Maris Veveris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivars Kalvinsh, Maris Veveris filed Critical Ivars Kalvinsh
Application granted granted Critical
Publication of ATE235901T1 publication Critical patent/ATE235901T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96927931T 1995-08-21 1996-08-20 Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen ATE235901T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-95-256A LV11728B (en) 1995-08-21 1995-08-21 Pharmaceutical composition
PCT/LV1996/000002 WO1997006794A1 (en) 1995-08-21 1996-08-20 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine

Publications (1)

Publication Number Publication Date
ATE235901T1 true ATE235901T1 (de) 2003-04-15

Family

ID=19736013

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96927931T ATE235901T1 (de) 1995-08-21 1996-08-20 Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen

Country Status (11)

Country Link
US (1) US5859056A (de)
EP (1) EP0845986B1 (de)
JP (1) JP3072858B2 (de)
AT (1) ATE235901T1 (de)
CA (1) CA2229228C (de)
DE (1) DE69627160T2 (de)
EA (1) EA000472B1 (de)
ES (1) ES2196167T3 (de)
LV (1) LV11728B (de)
UA (1) UA44330C2 (de)
WO (1) WO1997006794A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV12491B (lv) * 1998-10-29 2000-12-20 Ivars KALVIŅŠ Farmaceitiska kompozīcija
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
JP4390134B2 (ja) 2003-11-05 2009-12-24 日本精工株式会社 ステアリング装置
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
LV14274B (lv) * 2009-06-25 2011-03-20 Grindeks, A/S Meldoniju saturošs kombinēts medicīniskais produkts
WO2010149654A1 (en) * 2009-06-25 2010-12-29 Grindeks, A Joint Stock Company Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
LV14345B (lv) 2009-10-22 2011-07-20 Grindeks, A/S 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
ES2585558T3 (es) 2011-04-27 2016-10-06 Grindeks, A Joint Stock Company Uso de sales de 3-carboxi-N-etil-N,N-dimetilpropan-1-aminio en el tratamiento de una enfermedad cardiovascular
EA201301079A1 (ru) 2011-04-27 2014-02-28 Гриндекс, Джоинт Сток Кампани 4-[(галоидалкил)(диметил)аммоний]бутаноаты и их применение при лечении сердечно-сосудистого заболевания
LV14848B (lv) * 2012-10-25 2015-06-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai
GB201315321D0 (en) 2013-08-28 2013-10-09 Koninklijke Nederlandse Akademie Van Wetenschappen Transduction Buffer
CN112180013B (zh) * 2020-09-29 2022-11-15 上海脉示生物技术有限公司 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198434B (it) * 1981-01-06 1988-12-21 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
IT1210935B (it) * 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.

Also Published As

Publication number Publication date
CA2229228C (en) 2008-07-08
DE69627160T2 (de) 2004-02-12
US5859056A (en) 1999-01-12
EP0845986B1 (de) 2003-04-02
LV11728B (en) 1997-08-20
WO1997006794A1 (en) 1997-02-27
CA2229228A1 (en) 1997-02-27
EP0845986A1 (de) 1998-06-10
UA44330C2 (uk) 2002-02-15
JP3072858B2 (ja) 2000-08-07
JPH10512286A (ja) 1998-11-24
LV11728A (lv) 1997-04-20
EA000472B1 (ru) 1999-08-26
DE69627160D1 (de) 2003-05-08
EA199800160A1 (ru) 1998-08-27
ES2196167T3 (es) 2003-12-16

Similar Documents

Publication Publication Date Title
GEP20032958B (en) Adenosine Derivatives
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
ATE235901T1 (de) Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen
GEP20022656B (en) 2-(Purin-9-YL)-Tetrahydrofuran-3,4-Diol Derivatives
FI925342A0 (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
HUT77380A (hu) Kombinált gyógyszerkészítmény alkalmazása sclerosis multiplex (MS) és más demielizáló állapotok kezelésére
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
NZ331953A (en) Benzopyran derivatives having leukotriene-antagonistic action
ATE319715T1 (de) Antikonvulsive pseudofructopyranose sulfamate
MY113062A (en) Amide derivatives and their therapeutic use
ATE360428T1 (de) Analgetisches arzneimittel
TW261532B (de)
ATE326965T1 (de) Pharmazeutische zusammensetzung zur behandlung von autoimmunkrankheiten
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
HUP9701284A2 (hu) 2,3-Benzodiazepin-származékok felhasználása az endogén opioid rendszerrel összefüggő betegségek és állapotok kezelésére, és megelőzésére alkalmas gyógyászati készítmények előállítására
EP0784973A3 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0845986

Country of ref document: EP

EEIH Change in the person of patent owner